全文获取类型
收费全文 | 2337篇 |
免费 | 151篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 69篇 |
妇产科学 | 45篇 |
基础医学 | 322篇 |
口腔科学 | 9篇 |
临床医学 | 188篇 |
内科学 | 482篇 |
皮肤病学 | 68篇 |
神经病学 | 177篇 |
特种医学 | 121篇 |
外科学 | 227篇 |
综合类 | 61篇 |
一般理论 | 3篇 |
预防医学 | 161篇 |
眼科学 | 63篇 |
药学 | 226篇 |
中国医学 | 17篇 |
肿瘤学 | 216篇 |
出版年
2023年 | 26篇 |
2022年 | 44篇 |
2021年 | 55篇 |
2020年 | 40篇 |
2019年 | 45篇 |
2018年 | 49篇 |
2017年 | 38篇 |
2016年 | 56篇 |
2015年 | 54篇 |
2014年 | 87篇 |
2013年 | 74篇 |
2012年 | 127篇 |
2011年 | 143篇 |
2010年 | 76篇 |
2009年 | 91篇 |
2008年 | 128篇 |
2007年 | 115篇 |
2006年 | 114篇 |
2005年 | 95篇 |
2004年 | 105篇 |
2003年 | 95篇 |
2002年 | 79篇 |
2001年 | 57篇 |
2000年 | 46篇 |
1999年 | 55篇 |
1998年 | 17篇 |
1997年 | 19篇 |
1996年 | 14篇 |
1995年 | 13篇 |
1994年 | 17篇 |
1993年 | 17篇 |
1992年 | 34篇 |
1991年 | 39篇 |
1990年 | 38篇 |
1989年 | 28篇 |
1988年 | 26篇 |
1987年 | 30篇 |
1986年 | 27篇 |
1985年 | 28篇 |
1984年 | 25篇 |
1983年 | 20篇 |
1982年 | 13篇 |
1978年 | 10篇 |
1977年 | 10篇 |
1976年 | 18篇 |
1974年 | 12篇 |
1973年 | 14篇 |
1972年 | 14篇 |
1971年 | 11篇 |
1970年 | 15篇 |
排序方式: 共有2491条查询结果,搜索用时 0 毫秒
41.
Singh Ayesha Coulter Amanda R. Trainor Patrick J. Singam Narayana Sarma V. Aladili Bahjat N. Amraotkar Alok R. Owolabi Ugochukwu S. DeFilippis Andrew P. 《Journal of thrombosis and thrombolysis》2021,51(1):120-128
Journal of Thrombosis and Thrombolysis - Platelet activation and subsequent aggregation is a vital component of atherothrombosis resulting in acute myocardial infarction. Therefore, quantifying... 相似文献
42.
Sharma Arun Dev Agnish Suraj Kaur Inderjeet 《Proceedings of the National Academy of Sciences, India. Section B.》2021,91(4):971-983
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences - Cymbopogon khasianus (Hack.) is widely distributed and an underutilized plants in tropical and subtropical... 相似文献
43.
44.
Samiran Upadhyaya Achyut Konwar Devasish Chowdhury Neelotpal Sen Sarma 《RSC advances》2020,10(43):25408
Water-borne adhesives have immense importance in cellulose-based materials, where their durability, handling, and strength remain to be a major concern. The present work demonstrates the development of three water-borne adhesives, namely, poly(1-vinyl-2-pyrrolidone-co-acrylic acid), poly(acrylonitrile-co-acrylic acid), and poly(1-vinyl-2-pyrrolidone-co-acrylonitrile-co-acrylic acid) applicable for cellulose-based materials. These acrylic-acid based adhesives were characterized by Fourier-transform infra-red spectroscopy, thermogravimetric analysis, X-ray diffraction, gel permeation chromatography, and universal testing machine. The synthesized polymer adhesives can be stored in the powder form for a longer period, thus utilizing less space. In order to use as adhesives, suitable formulations can be prepared in water. The adhesives show thermal stability up to 300 °C. Our studies show that poly(1-vinyl-2-pyrrolidone-co-acrylonitrile-co-acrylic acid) showed higher lap shear strength (ASTM D-906) than commercially available adhesives. In addition, these adhesives, being fluorescent in nature, can be detected under UV light and thus are applicable for the detection of fractured joints of any specimen. This property also helps in anti-counterfeiting applications, thus adding further to their utility.Synthesis and application of a water-borne fluorescent acrylic adhesive, which can be stored as a powder for long-term use. 相似文献
45.
Gabriele?Donati Maria?Ilaria?Moretti Olga?Baraldi Alessandra?Spazzoli Irene?Capelli Giorgia?Comai Antonio?Marchetti Maria?Sarma Rita?Mancini Gaetano?La MannaEmail author 《BMC nephrology》2016,17(1):193
Background
Immunoglobulin light chains are classified as middle molecule uremic toxins able to interact with B lymphocyte membranes leading to the activation of transmembrane signaling. The ensuing impairment of neutrophil function can contribute to the chronic inflammation state of uremic patients, and the increased risk of bacterial infections or vascular calcifications. The aim of this crossover observational study was to assess the difference in free light chain removal by three different hemodialysis filters in patients not affected by multiple myeloma.Methods
Free light chain removal was compared in the polymethylmethacrylate (PMMA) membrane Filtryzer BK-F, the polyphenylene HFR17 filter and the conventional polysulfone filter F7HPS. Twenty chronic hemodialysis patients were enrolled: mean age was 67.7?±?17.0 years, M/F?=?14/6, dialysis vintage (months) 25.5?±?32.0. The patients were randomized into two groups of treatment lasting 6 weeks each. The dialysis sessions checked were the midweek sessions and the blood was drawn at times 0, 120’ and 240’. Kappa (k) and lambda (λ) light chain levels, β2microglobulin (β2M), C reactive protein (CRP) and albumin were checked.Results
K light chain levels were 345.0?±?100.0 mg/L, λ light chains were 121.4?±?27.0 mg/L. The values of k light chains at times 120’ and 240’ were significantly lower with PMMA and HFR17 than those obtained with F7. The reduction ratio per session (RRs) for k light chains was 44.1?±?4.3% with HFR17, 55.3?±?3.4% with PMMA, 25.7?±?8.3% with F7 (p?=?0.018). The RRs for λ light chains was 30.3?±?2.9% with HFR17, 37.8?±?17.3% with PMMA, 14.0?±?3.9% with F7 (p?=?0.032). As to β2M, RRs was 42.4?±?3.2% with HFR17 vs. 33.9?±?2.8% with PMMA vs. 6.3?±?1.9% with F7 (p?=?0.022). The three filters tested showed no differences in CRP or albumin levels.Conclusion
In terms of light chain and β2M removal, the PMMA and on-line HFR filters are similar and both are significantly more effective than the F7 filter in chronic dialysis patients.Trial registration
The present trial was registered retrospectively (NCT02950389, 31/10/2016).46.
Chronic hepatitis C infection is associated with significant morbidity and mortality in addition to substantial social and
health-related costs. Since the identification of the virus and determination of the HCV genome over a decade ago, considerable
progress has been made in the treatment of chronic hepatitis C infection. However, the current standard combination of interferon-based
therapies and ribavirin is effective in only 50% of patients. In addition, this combination is expensive, requires lengthy
periods of administration, and is associated with significant side effects. Furthermore, no effective preventive measure,
such as vaccination, is currently available. A number of newer therapies, including protease and helicase inhibitors, ribozymes,
antisense therapies, and therapeutic vaccines, are in preclinical and clinical development and may significantly enhance existing
therapeutic options for the future. 相似文献
47.
48.
Yan KK Guirgis M Dinh T George J Dev A Lee A Zekry A 《World journal of gastroenterology : WJG》2008,14(21):3416-3420
AIM:To conduct a multicentre retrospective review of virological response rates in Asians infected with genotype 1 chronic hepatitis C(CHC) treated with combination interferon and ribavirin and then to compare their responses to that among Caucasians.
METHODS:Asian patients infected with genotype 1 CHC treated at 4 Australian centres between 2001 to 2005 were identified through hospital databases.Baseline demographic characteristics,biochemical,virological and histological data and details of treatment were collected.Sustained virological responses(SVR) in this cohort were then compared to that in Caucasian subjects,matched by genotype,age,gender and the stage of hepatic fibrosis.
RESULTS:A total of 108 Asians with genotype 1 CHC were identified.The end of treatment response(ETR) for the cohort was 79% while the SVR was 67%.Due to the relatively advanced age of the Asian cohort,only sixty-four subjects could be matched with Caucasians.The ETR among matched Asians and Caucasians was 81% and 56% respectively(P=0.003),while the SVR rates were 73% and 36%(P 〈0.001) respectively.This difference remained significant after adjusting for other predictive variables.
CONCLUSION: Genotype 1 CHC in Asian subjects is associated with higher rates of virological response compared to that in Caucasians. 相似文献
METHODS:Asian patients infected with genotype 1 CHC treated at 4 Australian centres between 2001 to 2005 were identified through hospital databases.Baseline demographic characteristics,biochemical,virological and histological data and details of treatment were collected.Sustained virological responses(SVR) in this cohort were then compared to that in Caucasian subjects,matched by genotype,age,gender and the stage of hepatic fibrosis.
RESULTS:A total of 108 Asians with genotype 1 CHC were identified.The end of treatment response(ETR) for the cohort was 79% while the SVR was 67%.Due to the relatively advanced age of the Asian cohort,only sixty-four subjects could be matched with Caucasians.The ETR among matched Asians and Caucasians was 81% and 56% respectively(P=0.003),while the SVR rates were 73% and 36%(P 〈0.001) respectively.This difference remained significant after adjusting for other predictive variables.
CONCLUSION: Genotype 1 CHC in Asian subjects is associated with higher rates of virological response compared to that in Caucasians. 相似文献
49.
50.
Felicity Payne Koini Lim Amandine Girousse Rebecca J. Brown Nora Kory Ann Robbins Yali Xue Alison Sleigh Elaine Cochran Claire Adams Arundhati Dev Borman David Russel-Jones Phillip Gorden Robert K. Semple Vladimir Saudek Stephen O’Rahilly Tobias C. Walther Inês Barroso David B. Savage 《Proceedings of the National Academy of Sciences of the United States of America》2014,111(24):8901-8906
Phosphatidylcholine (PC) is the major glycerophospholipid in eukaryotic cells and is an essential component in all cellular membranes. The biochemistry of de novo PC synthesis by the Kennedy pathway is well established, but less is known about the physiological functions of PC. We identified two unrelated patients with defects in the Kennedy pathway due to biallellic loss-of-function mutations in phosphate cytidylyltransferase 1 alpha (PCYT1A), the rate-limiting enzyme in this pathway. The mutations lead to a marked reduction in PCYT1A expression and PC synthesis. The phenotypic consequences include some features, such as severe fatty liver and low HDL cholesterol levels, that are predicted by the results of previously reported liver-specific deletion of murine Pcyt1a. Both patients also had lipodystrophy, severe insulin resistance, and diabetes, providing evidence for an additional and essential role for PCYT1A-generated PC in the normal function of white adipose tissue and insulin action.All living cells are surrounded by a lipid membrane. Eukaryotic cells also contain several internal membrane-bound organelles, which enable them to compartmentalize related biological functions and thereby to enhance the efficiency of these processes. Phospholipids are the predominant component of these membranes. Their hydrophilic head groups interact with the cytosol, whereas their hydrophobic side chains are either buried within the hydrophobic interior of a typical membrane bilayer or interact with the hydrophobic neutral lipid core of lipoproteins and lipid droplets (LDs). Phospholipids are generally defined by their organic head group with phosphatidylcholine (PC) constituting over 50% of all membrane phospholipids. PC was first isolated in the 19th century and the major enzymatic pathway involved in its synthesis was revealed by Kennedy and Weiss (1) in the 1950s. Cells synthesize PC in three consecutive steps (Fig. 1A): choline kinase phosphorylates choline before choline phosphate cytidylyltransferase 1 α (encoded by the PCYT1A gene) generates the high-energy donor CDP-choline in the rate-limiting step of the pathway. In the last step, DAG:CDP-choline cholinephosphotransferase (CPT) uses CDP-choline and diacylglycerol (DAG) to form PC (2, 3).Open in a separate windowFig. 1.Cosegregation of biallelic PCYT1A mutations with fatty liver, low HDL cholesterol levels, lipodystrophy, insulin-resistant diabetes, and short stature. (A) Schematic illustration of the Kennedy PC synthesis pathway. CK, choline kinase; CPT, CDP-choline:1,2-diacylglycerol cholinephosphotransferase; PCYT1A, choline-phosphate cytidylyltransferase A, CTP:phosphocholine-cytidylyltransferase. (B) Family pedigrees of both probands demonstrating that only compound heterozygous carriers of PCYT1A mutations manifest fatty liver (red), low HDL cholesterol (blue), lipodystrophy (yellow), and insulin resistance/type 2 diabetes (T2DM) (green). PCYT1A mutation status, height (Ht.), and body mass index (BMI) are indicated below each individual’s symbol. ND, not determined; WT, wild type. (C) The location of PCYT1A mutations E280del, V142M, and 333fs in relation to known functional domains of PCYT1A. Domain M, membrane binding domain; domain P, phosphorylated region. (D) Conservation around the V142(red*) and E280(red*) mutation sites. Sequence alignment of representative metazoan sequences in the region surrounding the mutated residues. Hydrophobic (blue) and polar (green) residues interacting with V142 are highlighted. Only residues different from the human sequence are shown. Sequence IDs: human (Homo sapiens) , zebrafish (Danio rerio) F1QEN6, sea squirt (Ciona intestinalis) P49585, sea urchin (Strongylocentrotus purpuratus) H3I3V9, water flee (Daphnia pulex) E9G1P5, Drosophila (D. melanogaster) Q9W0D9, Caenorhabditis (C. elegans) XP_002130773.1, Trichoplax (T. adherens) B3RI62. (E and F) Structure of the catalytic domain of PCYT1A highlighting the role of V142M in the core packing. The two chains in the dimer are shown in yellow and gray; the residues and the secondary structure units are highlighted in color in the yellow monomer A: loop L3 with V142, red; α-helix, green; and the interacting β-sheet, blue. The residues packing with V142 are shown in ball-and-stick and space-filling representations, the dimer stabilizing R140 is shown in ball-and-stick colored according to the atom type. E is a global view, and F is a zoomed-in view of the catalytic core.Membrane phospholipids are a defining feature of advanced life-forms so it is perhaps not surprising that the pathways involved in their synthesis are ancient, and mutations affecting them are rarely tolerated in evolution. Here, we describe the identification and characterization of pathogenic human loss-of-function mutations affecting the eponymous Kennedy pathway. P49583相似文献